(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday. In December, the company said it was exploring a potential sale and other options that ...

After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb chairman and CEO Brent Saunders won't be making in 2025.The one for his contact lens maker ...

As a fully integrated eye health business, Bausch + Lomb has an established line of contact lenses, intraocular lenses (“IOLs”) and other medical devices, surgical systems and devices ...

and Daily SiHy lenses and Bausch + Lomb ULTRA ® in our contact lens business. Surgical segment revenue was $231 million for the fourth quarter of 2024, as compared to $204 million for the fourth ...

Feb 6 (Reuters) - Bausch + Lomb (BLCO.TO), opens new tab, will not be taken private at this time, the contact lens maker said on Thursday, sending its U.S.-listed shares down 7% to $16.50 in ...

Listen and subscribe to Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you find your favorite podcasts. After completing $300 billion in healthcare deals over several decades, there ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and full-year 2024 ...